Updated
DexComDXCM · Healthcare
$79.40-2.05%
Market cap$29.6B
IndustryMedical Devices
DexCom (DXCM) Superinvestor holders
21 of the superinvestors we track hold DexCom (DXCM) in their latest 13F filings, $2.2B in total.
Summary
The largest holder is Baillie Gifford (Baillie Gifford & Co), with $1.3B, 1.2% of the portfolio.
In their latest quarter: 1 opened a new position, 11 added, 9 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Baillie Gifford Baillie Gifford & Co |
Trimmed | 14,521,620 | $1.3B | 1.2% | Q3 2026 |
| Arrowstreet Capital | Added | 6,873,273 | $463M | 0.2% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 3,237,720 | $218M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 1,630,796 | $110M | 0.2% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 532,804 | $36M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 400,929 | $27M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Added | 394,449 | $27M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Added | 282,840 | $19M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 245,000 | $17M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 165,867 | $14M | 0.0% | Q3 2026 |
| PRIMECAP Management PRIMECAP Management Co |
New position | 192,000 | $13M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 140,932 | $9M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 102,500 | $7M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 58,484 | $5M | 0.0% | Q3 2026 |
| Alger Fred Alger Management |
Added | 57,972 | $4M | 0.0% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 52,000 | $4M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 46,697 | $3M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 32,813 | $2M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 5,679 | $382,481 | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Trimmed | 3,115 | $209,795 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Added | 976 | $65,734 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 21 |
| Q1 2026 | 22 |
| Q4 2025 | 23 |
| Q3 2025 | 24 |
| Q2 2025 | 22 |
| Q1 2025 | 23 |
| Q4 2024 | 24 |
| Q3 2024 | 26 |
Questions about DexCom
Which superinvestors own DexCom?
21 of the superinvestors we track hold DexCom (DXCM) in their latest 13F filings, $2.2B in total. Baillie Gifford, Arrowstreet Capital, Cliff Asness, Jim Simons, Paul Marshall, Ray Dalio.
Who is the largest superinvestor holder of DXCM?
The largest holder is Baillie Gifford (Baillie Gifford & Co), with $1.3B, 1.2% of the portfolio.
From DexCom's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.